THROMBOPOIETIN RECEPTOR LIGANDS FOR NEUROPROTECTION

摘要

The present invention provides therapeutic modalities for the treatment of an ischemic event (e.g., stroke) that creates or embodies a risk of neurological damage in CNS sites by administration of a thrombopoietin receptor ligand.

主权项

1. A method comprising steps of:
administering to a subject who is suffering from or has recently suffered a an ischemic event that creates or embodies a risk of neurological damage in CNS sites, a composition comprising a thrombopoietin receptor ligand, which composition is formulated and contains an amount of thrombopoietin receptor ligand sufficient to achieve delivery of the thrombopoietin receptor ligand to the CNS.